会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明公开
    • EINWEG-MIKROFLUIDIK-TESTKASSETTE ZUR BIOASSAY VON ANALYTEN
    • EP2416881A1
    • 2012-02-15
    • EP10711021.5
    • 2010-03-27
    • Bayer Technology Services GmbH
    • DORN, IngmarSCHADE, Andreas
    • B01L3/00C12Q1/68
    • B01L3/502B01L2200/16B01L2300/0816
    • The invention relates to a single-use test cartridge for the qualitative and/or quantitative analysis of analytes, comprising a structured body into which cavities that are connected to each other by channels are introduced, wherein the test cartridge comprises at least one inlet for introducing a test fluid containing the analyte, at least one reagent chamber in which one or more reagents for reacting with the analytes or for mixing with the sample fluid are accommodated, and at least one detection chamber in which a signal for proving or for the quantitative analysis of the analyte is detected, characterized in that the bottom or the top of the detection chamber comprises a signal converter or a window for detecting a signal, the channels are designed such that the fluid cannot be drawn into the reagent chamber or to the opening by capillary forces, and the reagents are accommodated in the reagent chamber and optionally further reactants are accommodated in the detection chamber in dry form. The invention further relates to a device for the bioassay of analytes by means of bio and/or chemo sensors, comprising the test cartridge according to the invention, at least one coupling point for positioning the test cartridge, at least one means for delivering the test fluids into the test cartridge, and at least one temperature control unit, and to a method for operating said device. The test cartridge, device and method according to the invention can be used in the field of environmental analytics, the food industry, human and veterinary diagnostics and plant protection in order to qualitatively and/or quantitatively determine analytes.
    • 一种一次性测试盒,用于对分析物进行定性和/或定量分析,其具有通过通道彼此连接的引入空腔的结构化体,用于引入含有分析物的样品流体的至少一个入口,至少一个试剂室, 存储更多的试剂,并且至少一个检测室,其中检测到用于分析物的检测或定量分析的信号,其中检测室的底板或天花板是用于检测信号的信号转换器或窗口,流体不能 通过毛细管拉入试剂室或开口,并且至少试剂室中的试剂以干燥形式储存。 还公开了一种用于生物分析包括测试盒的分析物的装置,以及用于操作该装置的方法。
    • 10. 发明公开
    • VERFAHREN ZUR BESTIMMUNG EINER WIRKSTOFFDOSIERUNG
    • 方法确定活性剂量
    • EP1671250A2
    • 2006-06-21
    • EP04765437.1
    • 2004-09-21
    • Bayer Technology Services GmbH
    • SCHMITT, WalterWILLMANN, StefanDIEßEL, EdgarDORN, IngmarBURMEISTER, Jens
    • G06F19/00
    • G06F19/18G06Q50/24
    • The invention relates to a method for determining the dosage of at least one active ingredient based on a genetic analysis. The method comprises the following steps: a) analysis (101) of specific genetic sequences, using a genetic sequence-specific analysis device, in particular a sequence-specific sensor, or determination of the expression of proteins, either by RNA transcription using quantitative RNA-specific identification methods or by the direct measurement of the protein expression by a protein analysis device; b) assignment of the genetic sequences to physiological functions of the human or animal body, in particular to those physiological functions that influence the decomposition, absorption, release or distribution behaviour of the active ingredient in the body; c) transmission of the genetic and assignment data to a physiology-based pharmacokinetic model (PBPK model) (108); d) input of active ingredient-specific data into the PBPK model (108); e) input of characteristic patient data, optionally from direct measurements on the body; f) calculation of physiological influence parameters that are required for the PBPK model from the patient data, using information contained in the knowledge database and transmission of said parameters to the PBPK model (108); g) calculation of the individual dose from the data in steps c), d) and f), using the PBPK model (108).